Key Takeaways
- • Vienna-based BlueBalance Capital, co-founded by Michael Schülli, manages €450m and pursues derivatives-market pricing dislocations on 12-24 month holding periods.
- • Schülli argues that long lockups and a long-term trading style are different things, and that many firms with long lockups do not actually trade with a long-term horizon.
- • BlueBalance reports 11.80% annualised performance over the last three years, a Sharpe ratio just under 2, and positive returns in 30 of the last 36 months, per the article.
- • The fund's approach relies on temporal diversification: its patient horizon behaves differently from monthly-return-focused capital during market stress.
- • The article frames the strategy as an answer to quarterly and monthly performance pressure that forces short-horizon managers to exit trades early.
Summary
The debate over short-termism was renewed when US President Donald Trump recently called for US companies to move from quarterly reporting to semi-annual disclosures, contrasting this with China's longer-term management view. Hedgeweek uses the remark as a starting point to examine how the hedge fund industry measures success, arguing that the real issue is investment philosophy rather than reporting frequency.
The article draws a distinction between long-term lockups and long-term trading style. According to Michael Schülli, co-founder of Vienna-based BlueBalance Capital, many firms with long lockups do not have a long-term trading style. BlueBalance manages €450m across derivatives markets, hunting pricing dislocations and holding positions for 12-24 months, because that is the time mispricings can take to correct rather than because capital is locked up.
Schülli describes the core uncertainty as one of timing rather than outcome. The team targets parameters trading at statistical extremes, typically above the 90th percentile, and waits for mean reversion. The article cites a clearing basis trade of identical swaps between exchanges as an example that may take months to monetise, though the terminal probability of success is described as very high. The fund distinguishes signal, a medium-term dislocation likely to monetise, from noise, short-term market moves it considers irrelevant to its strategy.
The article argues that monthly performance expectations, reinforced by quarterly investor reviews, push many funds to monetise positions quickly and leave medium-term opportunities underexploited. BlueBalance's 90 concurrent positions maintain near-zero pairwise correlation, which the article attributes partly to trading in a less crowded time horizon. Schülli notes that diversification can come from time as well as from asset classes and risk factors.
The fund's 15-year track record is cited with performance of 11.80% p.a. over the last three years, a Sharpe ratio just under 2, and positive performance in 30 of the last 36 months, despite accepting some mark-to-market volatility. Schülli states, "We accept that it's about delivering over annual horizons, not monthly." The article presents this as a case for allocators to align evaluation periods with a strategy's time horizon.
The article draws a distinction between long-term lockups and long-term trading style. According to Michael Schülli, co-founder of Vienna-based BlueBalance Capital, many firms with long lockups do not have a long-term trading style. BlueBalance manages €450m across derivatives markets, hunting pricing dislocations and holding positions for 12-24 months, because that is the time mispricings can take to correct rather than because capital is locked up.
Schülli describes the core uncertainty as one of timing rather than outcome. The team targets parameters trading at statistical extremes, typically above the 90th percentile, and waits for mean reversion. The article cites a clearing basis trade of identical swaps between exchanges as an example that may take months to monetise, though the terminal probability of success is described as very high. The fund distinguishes signal, a medium-term dislocation likely to monetise, from noise, short-term market moves it considers irrelevant to its strategy.
The article argues that monthly performance expectations, reinforced by quarterly investor reviews, push many funds to monetise positions quickly and leave medium-term opportunities underexploited. BlueBalance's 90 concurrent positions maintain near-zero pairwise correlation, which the article attributes partly to trading in a less crowded time horizon. Schülli notes that diversification can come from time as well as from asset classes and risk factors.
The fund's 15-year track record is cited with performance of 11.80% p.a. over the last three years, a Sharpe ratio just under 2, and positive performance in 30 of the last 36 months, despite accepting some mark-to-market volatility. Schülli states, "We accept that it's about delivering over annual horizons, not monthly." The article presents this as a case for allocators to align evaluation periods with a strategy's time horizon.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.